{"title": "Press Release: Funding Late-Stage Development of M72 TB Vaccine Candidate", "author": null, "url": "https://www.gatesfoundation.org/ideas/media-center/press-releases/2023/06/funding-commitment-m72-tb-vaccine-candidate", "hostname": "gatesfoundation.org", "description": "Wellcome and the Bill & Melinda Gates Foundation today announced funding to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical trial.", "sitename": "Bill & Melinda Gates Foundation", "date": "2023-06-01", "cleaned_text": "Wellcome and the Gates Foundation to Fund Late-Stage Development of a Tuberculosis Vaccine Candidate That Could Be the First in 100 Years If Proven Effective Sign up for The Optimist newsletter Subscribe to The Optimist to get weekly updates on the latest in global health, gender equality, education, and more. More about the foundation Our story Learn about the origins of the foundation and the values that drive our work. Our work Learn about where we work around the globe and the programs we've created to address urgent issues in global health, global development, and education. Ideas Read the latest stories, research, and news from across the foundation and subscribe to our weekly newsletter, The Optimist. "}